Intermediates
Intermediates |
||
| S.No. | Intermediate | CAS No. |
|---|---|---|
Ranitidine Intermediates |
||
| 1 | NMSM N-methyl-1-methylthio-2-nitroethenamine |
61832-41-5 |
| 2 | Cystophur Pure 5-[[2-aminoethyl) thio] methyl]-N, N-dimethyl-2-furanmethanamine 2HCl |
66356-53-4 |
| 3 | Ranitidine Aqueous Solution Technical N-[2-[[[5-[(Dimethylamino) methyl]-2-furanyl] methyl] thio] ethyl]-N’-methyl-2-nitro-1, 1-ethenediamine |
– – – |
| 4 | Ranitidine Base N-[2-[[[5-[(Dimethylamino) methyl]-2-furanyl] methyl] thio] ethyl]-N’-methyl-2-nitro-1, 1-ethenediamine |
66357-35-5 |
Gabapentin Intermediates |
||
| 1 | Gabapentin HCl (1-Aminomethyl Cyclohexan acetic Acid Hydrochloride) |
60142-95-2 |
| 2 | 2, 2-(cyclohexane 1, 1-diyl) diacetic acid. ( CDA) | 07-11-4355 |
| 3 | 1, 1-Cyclohexanediacetic Acid Monoamide ( CAM) | 99189-60-3 |
Pantoprazole Intermediates |
||
| 1 | 2-(Chloro methyl)-3, 4-Dimethoxy pyridine hydrochloride (Chloro compound) | 72830-09-02 |
| 2 | 5-Difluoro Methoxy 2-Mercapto Benzimidizole | 97963-62-7 |
| 3 | 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole (Sulphide compound) | 102625-64-9 |
Pregabalin Intermediates |
||
| 1 | (R,S)-3-(Carbamoylmethyl)-5-methylHexanoic acid (CMH) (or) 3-(2-amino-2-oxoethyl)-5-methylhexanoic acid |
181289-15-6 |
| 2 | (R)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid (RCMH) | 181289-33-8 |
Triclabendazole intermediates |
||
| 1 | 5-Chloro-6-(2, 3-Dichlorophenoxy)-1H-Benzimidazole-2-Thiol (TCB-III) (OR) 5-Chloro-6-(2, 3-dichlorophenoxy)-1, 3-dihydro-2H-Benzimidazole-2-thione (TCB-III) | 68828-69-3 |
Azoxystrobin Intermediates |
||
| 1 | 4, 6-Dihydroxypyrimidine (DHP) | 1193-24-4 |
| 2 | 4, 6-Dichloropyrimidine (DCP) | 1193-21-1 |
Sertraline intermediate |
||
| 1 | Tetralone imine (Schiff base) (4-(3, 4-dichlorophenyl)-N-methyl-3, 4-dihydronaphthalen-1(2H)-imine | 79560-20-6 |
Saraca is a WHO-GMP certified company and Approved by USFDA, TGA, KFDA (MFDS-Korea) & PMDA-Japan
